Fox Run Management, L.L.C. Moderna, Inc. Transaction History
Fox Run Management, L.L.C.
- $553 Million
- Q2 2025
A detailed history of Fox Run Management, L.L.C. transactions in Moderna, Inc. stock. As of the latest transaction made, Fox Run Management, L.L.C. holds 20,813 shares of MRNA stock, worth $554,874. This represents 0.1% of its overall portfolio holdings.
Number of Shares
20,813
Previous 11,969
73.89%
Holding current value
$554,874
Previous $339,000
69.32%
% of portfolio
0.1%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
856Shares Held
266MCall Options Held
28.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA41.7MShares$1.11 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$681 Million0.07% of portfolio
-
Baillie Gifford & CO22.1MShares$589 Million0.48% of portfolio
-
State Street Corp Boston, MA17.3MShares$460 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA8.88MShares$237 Million0.02% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $10.4B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...